<PAGE>
---------------------------------
OMB APPROVAL
---------------------------------
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per response..........14.90
---------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 5)*
Roberts Pharmaceutical Corporation
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
770491-10-8
- --------------------------------------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [_]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 pages
<PAGE>
CUSIP No. 770491-10-8 13G Page 2 of 5 Pages
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert A. Vukovich
Social Security ####-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5 SOLE VOTING POWER
2,019,571
6 SHARED VOTING POWER
216,000
7 SOLE DISPOSITIVE POWER
2,019,571
8 SHARED DISPOSITIVE POWER
216,000
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,235,571
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
12%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 5 pages
<PAGE>
SCHEDULE 13G (continued)
Item 1 (a) Names of Issuer:
Roberts Pharmaceutical Corporation
Item 1 (b) Address of Issuer's Principal Executive Offices:
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
Item 2 (a) Name of Person Filing:
Robert A. Vukovich
Item 2 (b) Address of Principal Office or, if none, Residence:
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
Item 2 (c) Citizenship:
U.S.A.
Item 2 (d) Title of Class of Securities:
Common Stock, $.01 par value.
Item 2 (e) CUSIP Number:
770491-10-8
Item 3 If this statement if filed pursuant to Rules 13d-1(b), or 13d-2(b), check
whether the person filing is a:
Not Applicable.
Item 4 Ownership
(a) Amount Beneficially Owned:
(b) Percent of Class:
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote of 2,019,571 shares
including 167,000 shares subject to a currently exercisable
option.
Page 3 of 5
<PAGE>
(ii) shared power to vote or to direct the vote of 216,000 shares.
(iii) sole power to dispose or to direct the disposition of 2,019,571
shares including 167,000 shares subject to a currently
exercisable option.
(iv) shared power to dispose of or to direct the disposition of
216,000 shares.
Item 5 Ownership of Five Percent or Less of a Class
Not Applicable.
Item 6 Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable.
Item 7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not Applicable.
Item 8 Identification and Classification of Members of the Group
Not Applicable.
Item 9 Notice of Dissolution of Group
Not Applicable.
Page 4 of 5
<PAGE>
Item 10 Certification
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: May 1, 1995
/s/ Robert A. Vukovich
- ----------------------------
Signature
Robert A. Vukovich/
Chairman of the Board and
President
- ----------------------------
Name/Title
Page 5 of 5
